UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy
    Katherine Hadlandsmyth
  2. Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarco…
    Ayman El-Sheikh
  3. A Randomized Phase II Study of Sequential Biotherapy with Aflibercept and High Dose IL-2 vs High Dose IL-2 Alone in Patients with Inoperable Stage III or Stage IV Melanoma: Efficacy and Biomarker Stud…
    Mohammed Milhem
  4. Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas(PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC…
    Ayman El-Sheikh
  5. A Phase II Study for the Treatment of Non-Metastatic Nodular Desmoplastic Medulloblastoma in Children Less than 4 years of age
    Ayman El-Sheikh
  6. A Randomized Phase 2 Trial of Axitinib and TRC105 versus Axitinib alone (Including a Lead-in Phase 1B Dose-Escalation Portion) in Patients with Advanced or Metastatic Renal Cell Carcinoma
    Daniel Vaena
  7. Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
    Daniel Vaena
  8. A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxyge…
    Dilek Ince
  9. A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Sunitinib Monotherapy in Subjects with Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma
    Daniel Vaena
  10. Preoperative Assessment and Post-Operative Outcomes of Elderly Women with Gynecologic Cancers
    David Bender
  11. Quantitative Assessment of Minimal Detectable Disease in N0 and N1 Head and Neck Cancers
    John Sunderland
  12. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine with or without Birinapant with a Single Arm Open-Label Run-In Phase in Subjects with Higher Risk Myelodysplastic Syndrome…
    Rupali Roy
  13. Phase 2 Efficacy and Safety Study of Intravenous GPX-150, an Anthracycline Analog, in Patients with Soft Tissue Sarcoma
    Mohammed Milhem
  14. A Randomized Controlled Phase 3 Study of Oral Pacritinib versus Best Available Therapy in Patients with Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essent…
    Usha Perepu
  15. Phase 1 / Comparative Randomized Phase II Trial of TRC105 + Bevacizumab vs Bevacizumab in Bevacizumab-Naive Patients with Recurrent Glioblastoma Multiforme
    Mohammed Milhem
  16. A Phase 1, First-in-Human, Single-Dose, Open-label, Positron Emission Tomography(PET) Imaging Study of [68Ga]MLN6907 in Patients with Metastatic Colorectal Carcinoma
    Daniel Berg
  17. An Open Label, Randomized (2:1) Phase IIb Study of Dasatinib Versus Imatinib in Patients With Chronic Phase Chronic Myeloid Leukemia Who Have Not Achieved an Optimal Response to 3 Months of Therapy Wi…
    Usha Perepu
  18. A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Docetaxel in Combination with 1-m(1)
    Alexandra Thomas
  19. A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABF(1)
    Ayman El-Sheikh
  20. Phase I/II Study of the Concomitant Administration of Indoximod Plus Ipilimumab for Adult Patients with Metastatic Melanoma
    Yousef Zakharia

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.